This Hated 6.8% Payer Is Ready To Pop (Buy Now)

| July 11, 2018 | 0 Comments

buy nowIt’s here again: another stock downturn.

But don’t worry, because today I’m going to show you a “1-click” way to profit from it (and collect a nice 6.8% dividend while you do).

The key? Dipping into an out-of-favor sector that outperforms when the market gets fearful. I’m talking about consumer staples, which is down a whopping 9.4% in 2018, far below every other sector in the S&P 500.

Consumer Staples Swoons

Usually, when volatility picks up, consumer staples outperform consumer-discretionary stocks. Yet that didn’t happen from February to April, when the market first began to tumble, and it isn’t happening now that the market is beginning to fall again.

In fact, the Consumer Staples Select Sector SPDR ETF (XLP) has fallen by almost exactly as much as the Consumer Discretionary Select Sector SPDR ETF (XLY) has risen in 2018, suggesting investors are simply selling off the one to buy the other.

Investors Ditch So-Called “Safe” Stocks Despite Market Wobbles

So where is this market confidence in the relative weakness of staples coming from, if investors are also scared that US stocks are generally riskier than they looked in January?

The answer may come down to changing consumer preferences. A big part of the sector is consumer-packaged goods (CPGs), a group that includes everything from Procter & Gamble (PG) to tobacco producer Altria (MO) and well-known brands such as General Mills (GIS).

And, taken as a whole, these firms just aren’t selling as much as they used to.

Big Names, Weak Sales

With the exception of Altria, which has benefited from a trend in vaping that’s helped drive tobacco sales higher, these firms’ sales are down, and there’s little evidence they’ll recover.

But keep in mind that this trend is well known and is why staples have underperformed consumer-discretionary stocks for years.

Underperformance Serves Up Bargains

Notice, however, that consumer discretionary’s outperformance has increased significantly in the last few months, which may indicate that the market has oversold the weakness in consumer staples, providing some bargains in the sector.

And while the sector is being challenged by changes in the market, there are standouts that can likely withstand the pressures. Take Altria. This tobacco producer has been able to grow EPS by 111.7% in the last 20 years, even though revenue has fallen by 55.1%:

Higher Profits on Lower Sales


That is why Altria has far exceeded the sector’s performance and even matched the performance of the Consumer Discretionary Select Sector SPDR ETF in the last few years, up until a few months ago.

Leading a Weak Sector

This doesn’t mean that all staples are destined to recover—or even that they will start to tick upward over the long term. As my colleague Brett Owens points out, firms with shrinking sales, like Altria, can’t squeeze out profits forever—but the question to ask yourself is whether some firms’ profit-making abilities have been discounted too much by the accelerated declines in staples stocks in the last few weeks.

For an investor who can answer this question and find the staples firms that can outperform thanks to higher earnings and exaggerated stock-price declines, the recent extreme selloff in the sector is a rare buying opportunity.

But how do you know which staples stocks to buy and which to avoid?

The Main Consumer Staples ETF Is Not the Answer

Since some staples companies can’t match Altria’s earnings growth, despite falling sales, just buying the index isn’t a way to make this contrarian play.

Instead, there is a fund that gives you exposure to the best staples companies while also providing a high yield and strong performance.

You get all of this with the Eagle Capital Growth Fund (GRF), a closed-end fund that yields 6.8% (XLP, by the way, yields just 3.7%) and holds many consumer-staples stocks, including Colgate-Palmolive (CL), its top holding, as well as Kraft Heinz (KHC), Procter & Gamble (PG)Pepsi (PEP) and Johnson & Johnson (JNJ).

And, when we look at the last 3 years, GRF has matched the performance of the consumer-discretionary ETF performance while beating the consumer-staples ETF for years—that is, until the recent downturn in staples:

A Buying Opportunity Appears


The reason I say now is a buying opportunity is because GRF’s recent decline is largely affected by its staples holdings, while the fund’s other holdings have crushed both the consumer-discretionary ETF and the market more broadly.

While GRF is heavily invested in consumer staples, it also provides investors with exposure to high-performing stocks like T. Rowe Price (TROW), Ebay (EBAY) and Stryker (SYK), its biggest holdings behind Colgate. And in case you were wondering, here’s how these stocks have performed in the last 3 years:

Top Holdings Lead the Way

An 18.3% annualized gain over 3 years is impressive enough and shows GRF is a good pick not only for consumer-staples exposure but also for access to a fund-management team that has made great investment decisions in the past.

Now there’s something else I need to tell you about…

REVEALED: The Secret to Safe 8% Dividends Paid Monthly

My breakthrough 8% “Monthly Dividend” portfolio gives you 2 unbeatable tools that let you retire rich on a lot less than the so-called “experts” say you need:

  • A life-changing 8% dividend yield—enough for you let loose a $40,000-a-year income stream on a $500,000 nest egg.
  • Dividends paid monthly, so you don’t have to struggle to manage a cash flow that comes in quarterly while your bills come in every month!

PLUS if you’re not leaning on your portfolio for income, you can parlay these gaudy 8% payouts back into these “elite 8” stocks even faster, growing your nest egg and your dividend stream in the process. It really is a set-it-and-forget-it wealth-building machine!

(I’ll show you this powerful retirement package now—FREE!)

To convert your portfolio over to this 8-stock powerhouse portfolio, you really need to do only 2 things:

  1. SELL EVERYTHING, including the 2%, 3% and even 4% payers that simply don’t yield enough to matter. And,
  2. Buy the 8 bargain monthly dividend payers I’ll show you.

That’s it!

Don’t be left out while other investors “lock in” their golden years with this powerful new portfolio. Simply CLICK HERE and I’ll give you all 8 of these stocks’ names, tickers, buy-under prices and more right now!


Tags: , , , , ,

Category: Closed-End Funds (CEFs), Sector ETFs

About the Author ()

Michael Foster is an Investment Strategist at Contrarian Outlook.

Please Leave a Comment